08/10/2003
ReGen Therapeutics Plc (the ‘Company’) announces that on 8 October 2003 it received notification from Mr P. Garrod that he is beneficially interested in 24,000,000 ordinary shares of the Company representing 10.69% of the current issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007